Transforming Clinical Trial Document Review with Governed AI Agents
How a global life sciences organization reduced review effort by 75%, accelerated compliance validation, and improved audit readiness using elsai's governed clinical intelligence platform.
100%
Traceability
90%
Reduced Task Repetition
75%
Reduced Manual Effort
Overview
A global life sciences organization conducting multi-site clinical trials across North America and Europe faced increasing pressure to manage growing volumes of regulatory, protocol, consent, and submission documentation. The organization needed a scalable approach to improve document quality, reduce compliance risks, and accelerate trial readiness without expanding review teams.
Business Challenge
Clinical trial teams were spending significant time manually reviewing protocols, informed consent forms (ICFs), regulatory submissions, and supporting documentation. Multiple review cycles, inconsistent document quality, and evolving regulatory requirements created operational bottlenecks.
01
Manual validation of clinical documents across multiple study teams.
02
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
03
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
04
Limited visibility into document quality and audit readiness.
05
Increasing costs associated with repetitive document review and drafting activities.
elsai Solution
elsai deployed a governed AI-powered clinical intelligence platform built on specialized agents designed to automate document review, validation, drafting, and compliance assessment.
Key elements of the solution included:
• An OCR pipeline that converted clinical documents into structured, AI-ready content.
• A Completeness Agent that automatically classified and assessed submitted documents.
• An Audit Compliance Agent that evaluated documents against configurable regulatory and quality requirements.
• An Audit Validation Agent that identified inconsistencies, missing information, and content quality issues.
• A Document Draft Agent that generated compliant clinical document drafts using approved source materials.
• ARMS observability and governance controls to monitor agent performance, outputs, and audit trails.
Business Impact
75% reduction in manual document review effort.
60% faster protocol and consent document validation cycles.
90% reduction in repetitive compliance-checking activities.
85% improvement in audit readiness across clinical documentation.
3x increase in document review throughput without increasing headcount.
3x increase in document review throughput without increasing headcount.
The elsai Advantage
• Governed AI agents purpose-built for life sciences workflows.
• Automated compliance and validation checks with evidence-backed findings.
• Faster clinical document preparation and review cycles.
• End-to-end auditability through ARMS observability.
• Human-in-the-loop governance for regulated environments.
• Flexible deployment across existing enterprise ecosystems.
Still relying on manual document reviews to ensure compliance? Automate clinical audits with elsai's governed AI agents now!
Let's build a solution tailored to your business needs.
Talk to our experts →
Overview
A global life sciences organization conducting multi-site clinical trials across North America and Europe faced increasing pressure to manage growing volumes of regulatory, protocol, consent, and submission documentation. The organization needed a scalable approach to improve document quality, reduce compliance risks, and accelerate trial readiness without expanding review teams.
Business Challenge
Clinical trial teams were spending significant time manually reviewing protocols, informed consent forms (ICFs), regulatory submissions, and supporting documentation. Multiple review cycles, inconsistent document quality, and evolving regulatory requirements created operational bottlenecks.
01
Manual validation of clinical documents across multiple study teams.
02
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
03
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
04
Limited visibility into document quality and audit readiness.
05
Increasing costs associated with repetitive document review and drafting activities.
elsai Solution
elsai deployed a governed AI-powered clinical intelligence platform built on specialized agents designed to automate document review, validation, drafting, and compliance assessment.
Key elements of the solution included:
• An OCR pipeline that converted clinical documents into structured, AI-ready content.
• A Completeness Agent that automatically classified and assessed submitted documents.
• An Audit Compliance Agent that evaluated documents against configurable regulatory and quality requirements.
• An Audit Validation Agent that identified inconsistencies, missing information, and content quality issues.
• A Document Draft Agent that generated compliant clinical document drafts using approved source materials.
• ARMS observability and governance controls to monitor agent performance, outputs, and audit trails.
Business Impact
75% reduction in manual document review effort.
60% faster protocol and consent document validation cycles.
90% reduction in repetitive compliance-checking activities.
85% improvement in audit readiness across clinical documentation.
3x increase in document review throughput without increasing headcount.
100% traceability through governed workflows and audit trails.
The elsai Advantage
• Governed AI agents purpose-built for life sciences workflows.
• Automated compliance and validation checks with evidence-backed findings.
• Faster clinical document preparation and review cycles.
• End-to-end auditability through ARMS observability.
• Human-in-the-loop governance for regulated environments.
• Flexible deployment across existing enterprise ecosystems.
Still relying on manual document reviews to ensure compliance? Automate clinical audits with elsai's governed AI agents now!
Let's build a solution tailored to your business needs.
Talk to our experts →
Overview
A global life sciences organization conducting multi-site clinical trials across North America and Europe faced increasing pressure to manage growing volumes of regulatory, protocol, consent, and submission documentation. The organization needed a scalable approach to improve document quality, reduce compliance risks, and accelerate trial readiness without expanding review teams.
Business Challenge
Clinical trial teams were spending significant time manually reviewing protocols, informed consent forms (ICFs), regulatory submissions, and supporting documentation. Multiple review cycles, inconsistent document quality, and evolving regulatory requirements created operational bottlenecks.
01
Manual validation of clinical documents across multiple study teams.
02
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
03
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
04
Limited visibility into document quality and audit readiness.
05
Increasing costs associated with repetitive document review and drafting activities.
elsai Solution
elsai deployed a governed AI-powered clinical intelligence platform built on specialized agents designed to automate document review, validation, drafting, and compliance assessment.
Key elements of the solution included:
• An OCR pipeline that converted clinical documents into structured, AI-ready content.
• A Completeness Agent that automatically classified and assessed submitted documents.
• An Audit Compliance Agent that evaluated documents against configurable regulatory and quality requirements.
• An Audit Validation Agent that identified inconsistencies, missing information, and content quality issues.
• A Document Draft Agent that generated compliant clinical document drafts using approved source materials.
• ARMS observability and governance controls to monitor agent performance, outputs, and audit trails.
Business Impact
75% reduction in manual document review effort.
60% faster protocol and consent document validation cycles.
90% reduction in repetitive compliance-checking activities.
85% improvement in audit readiness across clinical documentation.
3x increase in document review throughput without increasing headcount.
100% traceability through governed workflows and audit trails.
The elsai Advantage
• Governed AI agents purpose-built for life sciences workflows.
• Automated compliance and validation checks with evidence-backed findings.
• Faster clinical document preparation and review cycles.
• End-to-end auditability through ARMS observability.
• Human-in-the-loop governance for regulated environments.
• Flexible deployment across existing enterprise ecosystems.
Still relying on manual document reviews to ensure compliance? Automate clinical audits with elsai's governed AI agents now!
Let's build a solution tailored to your business needs.
Talk to our experts →
Overview
A global life sciences organization conducting multi-site clinical trials across North America and Europe faced increasing pressure to manage growing volumes of regulatory, protocol, consent, and submission documentation. The organization needed a scalable approach to improve document quality, reduce compliance risks, and accelerate trial readiness without expanding review teams.
Business Challenge
Clinical trial teams were spending significant time manually reviewing protocols, informed consent forms (ICFs), regulatory submissions, and supporting documentation. Multiple review cycles, inconsistent document quality, and evolving regulatory requirements created operational bottlenecks.
01
Manual validation of clinical documents across multiple study teams.
02
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
03
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
04
Limited visibility into document quality and audit readiness.
05
Increasing costs associated with repetitive document review and drafting activities.
elsai Solution
elsai deployed a governed AI-powered clinical intelligence platform built on specialized agents designed to automate document review, validation, drafting, and compliance assessment.
Key elements of the solution included:
• An OCR pipeline that converted clinical documents into structured, AI-ready content.
• A Completeness Agent that automatically classified and assessed submitted documents.
• An Audit Compliance Agent that evaluated documents against configurable regulatory and quality requirements.
• An Audit Validation Agent that identified inconsistencies, missing information, and content quality issues.
• A Document Draft Agent that generated compliant clinical document drafts using approved source materials.
• ARMS observability and governance controls to monitor agent performance, outputs, and audit trails.
Business Impact
75% reduction in manual document review effort.
60% faster protocol and consent document validation cycles.
90% reduction in repetitive compliance-checking activities.
85% improvement in audit readiness across clinical documentation.
3x increase in document review throughput without increasing headcount.
100% traceability through governed workflows and audit trails.
The elsai Advantage
• Governed AI agents purpose-built for life sciences workflows.
• Automated compliance and validation checks with evidence-backed findings.
• Faster clinical document preparation and review cycles.
• End-to-end auditability through ARMS observability.
• Human-in-the-loop governance for regulated environments.
• Flexible deployment across existing enterprise ecosystems.
Still relying on manual document reviews to ensure compliance? Automate clinical audits with elsai's governed AI agents now!
Let's build a solution tailored to your business needs.
Talk to us →
Overview
A global life sciences organization conducting multi-site clinical trials across North America and Europe faced increasing pressure to manage growing volumes of regulatory, protocol, consent, and submission documentation. The organization needed a scalable approach to improve document quality, reduce compliance risks, and accelerate trial readiness without expanding review teams.
Business Challenge
Clinical trial teams were spending significant time manually reviewing protocols, informed consent forms (ICFs), regulatory submissions, and supporting documentation. Multiple review cycles, inconsistent document quality, and evolving regulatory requirements created operational bottlenecks.
01
Manual validation of clinical documents across multiple study teams.
02
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
03
Difficulty identifying missing, inconsistent, or non-compliant information before submission.
04
Limited visibility into document quality and audit readiness.
05
Increasing costs associated with repetitive document review and drafting activities.
elsai Solution
elsai deployed a governed AI-powered clinical intelligence platform built on specialized agents designed to automate document review, validation, drafting, and compliance assessment.
Key elements of the solution included:
• An OCR pipeline that converted clinical documents into structured, AI-ready content.
• A Completeness Agent that automatically classified and assessed submitted documents.
• An Audit Compliance Agent that evaluated documents against configurable regulatory and quality requirements.
• An Audit Validation Agent that identified inconsistencies, missing information, and content quality issues.
• A Document Draft Agent that generated compliant clinical document drafts using approved source materials.
• ARMS observability and governance controls to monitor agent performance, outputs, and audit trails.
Business Impact
75% reduction in manual document review effort.
60% faster protocol and consent document validation cycles.
90% reduction in repetitive compliance-checking activities.
85% improvement in audit readiness across clinical documentation.
3x increase in document review throughput without increasing headcount.
100% traceability through governed workflows and audit trails.
The elsai Advantage
• Governed AI agents purpose-built for life sciences workflows.
• Automated compliance and validation checks with evidence-backed findings.
• Faster clinical document preparation and review cycles.
• End-to-end auditability through ARMS observability.
• Human-in-the-loop governance for regulated environments.
• Flexible deployment across existing enterprise ecosystems.
Still relying on manual document reviews to ensure compliance? Automate clinical audits with elsai's governed AI agents now!
Let's build a solution tailored to your business needs.
Talk to our experts →
elsai
Enterprise AI governance platform for agentic workflows. Transform your operations with confidence.
elsai
Enterprise AI governance platform for agentic workflows. Transform your operations with confidence.
elsai
Enterprise AI governance platform for agentic workflows. Transform your operations with confidence.
elsai
Enterprise AI governance platform for agentic workflows. Transform your operations with confidence.